Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Clinical Chemistry|September 23, 2006
Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naïve emergency department patientsPeter A Kavsak, Andrew R MacRae, Glenn E Palomaki, et al.
Clinical Chemistry|January 6, 2007
Long-term health outcomes associated with detectable troponin I concentrationsPeter A Kavsak, Alice M Newman, Viliam Lustig, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 20, 2007
Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarctionPeter A Kavsak, Andrew R MacRae, Alice M Newman, et al.
Clinical Biochemistry|December 23, 2009
Identification of myocardial injury in the emergency settingPeter A Kavsak, Andrew Worster, John J You, et al.
British Journal of Obstetrics and Gynaecology|May 1, 1993
Biparietal diameter and crown-rump length in fetuses with Down's syndrome: implications for antenatal serum screening for Down's syndromeN J Wald, D Smith, A Kennard, et al.
JCO Precision Oncology|January 7, 2022
Phase II Single-Arm Study to Assess Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2-Negative Tumors and HER2-Positive Circulating Tumor CellsHeather A Parsons, Erin R Macrae, Hao Guo, et al.
The Oncologist|March 4, 2015
Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic complete response in patients with early stage HER2-positive breast cancer: a meta-analysis of randomized prospective clinical trialsMellissa Hicks, Erin R Macrae, Mahmoud Abdel-Rasoul, et al.
Investigational New Drugs|June 5, 2014
A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancerMeng Zhao, Xueliang Pan, Rachel Layman, et al.
Elife|July 1, 2020
Structure of MlaFB uncovers novel mechanisms of ABC transporter regulationLjuvica R Kolich, Ya-Ting Chang, Nicolas Coudray, et al.
Prenatal Diagnosis|May 5, 2010
Second and first trimester estimation of risk for Down syndrome: implementation and performance in the SAFER studyAndrew R MacRae, Bernie N Chodirker, Gregory A Davies, et al.
Pageof 11